Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Geretti
A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Related publications
Neuropilin-1 Binds Vascular Endothelial Growth Factor 165, Placenta Growth Factor-2, and Heparin via Its B1b2 Domain
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Paracrine Expression of a Native Soluble Vascular Endothelial Growth Factor Receptor Inhibits Tumor Growth, Metastasis, and Mortality Rate
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Neuropilin-1-Mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-Dependent Endothelial Cell Migration
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling
Cancer Research
Cancer Research
Oncology
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
Clinical Cancer Research
Cancer Research
Oncology
Vascular Endothelial Growth Factor (VEGF)-D Stimulates VEGF-A, Stanniocalcin-1, and Neuropilin-2 and Has Potent Angiogenic Effects
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia Coli
Journal of Microbiology and Biotechnology
Applied Microbiology
Biotechnology
Medicine
Nuclear Receptor COUP-TFII Controls Pancreatic Islet Tumor Angiogenesis by Regulating Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Signaling
Cancer Research
Cancer Research
Oncology
Active Immunization Against the Vascular Endothelial Growth Factor Receptor Flk1 Inhibits Tumor Angiogenesis and Metastasis
Journal of Experimental Medicine
Medicine
Allergy
Immunology
